Sales & Marketing How war in the Middle East is disrupting medical supply chai... The impact of the geopolitical disruption is starting to tell on global supply chains for medicines and key chemicals for the pharmaceutical industry.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Commercial teams are running yesterday's plays. AI just chan... What leading companies are building now is fundamentally different: decision systems.
Sales & Marketing Sponsored What HCPs Say Pharma Gets Wrong About Survey Research Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, February ... February was a light month for agency and consultancy news, but a few interesting changes came through.
Sales & Marketing Sponsored Solution Spotlight: Modelling human myelin and predicting re... Demyelinating diseases, including multiple sclerosis (MS) and Charcot-Marie-Tooth (CMT) disease, present a substantial and escalating burden.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.